Sp818

PANEL DISCUSSION

Date
May 20, 2024

Presenters

Speaker Image for Morris Gordon
University of Central Lancashire, UK
Speaker Image for Vassiliki Sinopoulou
Speaker Image for Siddharth Singh
University of California San Diego
Speaker Image for Gordon Moran

Tracks

Related Products

Thumbnail for CHRONOLOGICAL AGE INFLUENCES TREATMENT DECISION IN INFLAMMATORY BOWEL DISEASE
CHRONOLOGICAL AGE INFLUENCES TREATMENT DECISION IN INFLAMMATORY BOWEL DISEASE
BACKGROUND: Despite older adults making up roughly one quarter of patients with inflammatory bowel disease (IBD) in the United States, they are an understudied population…
Thumbnail for INCIDENCE AND PREVALENCE OF INFLAMMATORY BOWEL DISEASES IN HISPANICS IN THE UNITED STATES, 2011-2020
INCIDENCE AND PREVALENCE OF INFLAMMATORY BOWEL DISEASES IN HISPANICS IN THE UNITED STATES, 2011-2020
BACKGROUND & AIMS: Hispanics account for 19% (62 million) of the US population, of whom 2/3rd are US born; with global and regional immigration patterns, Hispanics are expected to increase to 30% of the US population (111 million) by 2060…
Thumbnail for PANEL DISCUSSION
Thumbnail for PATIENTS WITH INFLAMMATORY BOWEL DISEASE ARE AT INCREASED RISK FOR COMPLICATIONS OF HERPES ZOSTER
PATIENTS WITH INFLAMMATORY BOWEL DISEASE ARE AT INCREASED RISK FOR COMPLICATIONS OF HERPES ZOSTER
Patients with inflammatory bowel disease (IBD) are at an increased risk for vaccine-preventable diseases, such as herpes zoster (HZ). The aim of this study was to determine whether complications of HZ are more frequent in patients with IBD than in non-IBD controls…